Home News & Articles Bench-to-bedside: NIMH research leads to brexanolone, first-ever drug specifically for postpartum depression Bench-to-bedside: NIMH research leads to brexanolone, first-ever drug specifically for postpartum depression 20/03/2019 Approximately 1 in 9 women in the United States experiences symptoms. Read More
